Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cartesian Therapeutics (RNAC) Return on Assets (2016 - 2025)

Cartesian Therapeutics (RNAC) has disclosed Return on Assets for 10 consecutive years, with 0.41% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 33.0% to 0.41% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.41% through Dec 2025, down 33.0% year-over-year, with the annual reading at 0.36% for FY2025, 15.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.41% at Cartesian Therapeutics, down from 0.22% in the prior quarter.
  • The five-year high for Return on Assets was 0.15% in Q3 2022, with the low at 1.18% in Q4 2023.
  • Average Return on Assets over 5 years is 0.25%, with a median of 0.21% recorded in 2025.
  • The sharpest move saw Return on Assets plummeted -130bps in 2023, then skyrocketed 109bps in 2024.
  • Over 5 years, Return on Assets stood at 0.08% in 2021, then surged by 248bps to 0.12% in 2022, then plummeted by -1043bps to 1.18% in 2023, then soared by 93bps to 0.08% in 2024, then tumbled by -399bps to 0.41% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.41%, 0.22%, and 0.2% for Q4 2025, Q3 2025, and Q2 2025 respectively.